Insulin Dosing Guidelines for Novolin 70/30

Introduction to Novolin 70/30 Dosing

The American Diabetes Association recommends that dosing of Novolin 70/30 should be titrated based on blood glucose monitoring, with patients with type 2 diabetes commonly requiring ≥1 unit/kg/day or higher 1, 2

The American College of Endocrinology suggests a starting dose for insulin-naïve patients of 10 units or 0.1-0.2 units/kg body weight per day, divided into two equal doses administered twice daily, 30 minutes before breakfast and dinner 1, 2
Patients with type 2 diabetes generally require ≥1 unit/kg/day, which is substantially higher than type 1 diabetes requirements 1, 2
When basal insulin exceeds 0.5 units/kg/day, guidelines recommend considering combination injectable therapy or regimen intensification rather than continuing to escalate premixed insulin alone 3

Adjust doses every 2 weeks based on self-monitoring of blood glucose, with a target fasting blood glucose of 90-150 mg/dL 1, 2
If ≥50% of fasting values exceed goal, increase dose by 2 units 4
If >2 fasting values/week are <80 mg/dL, decrease dose by 2 units 4

Hypoglycemia risk increases substantially with higher doses, requiring more frequent monitoring 2
Patients at elevated hypoglycemia risk (age >65 years, renal failure, poor oral intake) should use lower starting doses and more conservative titration 1

Add SGLT-2 inhibitor or thiazolidinedione to improve control and reduce insulin requirements, though consider potential side effects 3
Transition to basal insulin plus GLP-1 receptor agonist, which provides potent glucose-lowering with less weight gain and hypoglycemia compared to intensified insulin regimens 3
Convert to basal-bolus regimen for patients needing more precise dosing control 3, 5

Avoid using premixed insulin in patients with unpredictable eating patterns or those requiring more precise insulin dosing, as the fixed ratio limits flexibility 1
Do not continue escalating Novolin 70/30 indefinitely if A1C remains above target; this represents therapeutic inertia and increases hypoglycemia risk without proportional benefit 3
Maintain metformin when adding or intensifying Novolin 70/30, but discontinue sulfonylureas and DPP-4 inhibitors to avoid unnecessarily complex regimens and reduce hypoglycemia risk 1

For patients with a history of hypoglycemia, lower starting doses (closer to 0.1 units/kg/day or even less) are recommended, as these patients face substantially higher hypoglycemia risk and require more conservative titration, according to guidelines from the American Association of Clinical Endocrinologists 6
Human regular/NPH 70/30 products can be purchased at significantly lower cost than analog premixed insulins at select pharmacies, making them accessible options for cost-conscious patients, as reported in Diabetes Care 6